NSAV Announces Launch of Tokenization, Listing and Blockchain Program
May 24, 2022
Healthcare Providers & Services
-
-
QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
May 24, 2022
-
BIMI International Medical Announces First Quarter 2022 Financial Results
May 20, 2022
-
NSAV Majority Shareholder Retires 500 Million Shares
May 19, 2022
-
NUROSENE’S CHIEF SCIENTIFIC OFFICER PUBLISHES PAPER ON AI AND PLACEBO RESPONSE
May 19, 2022
-
Nurosene Completes Population Stratification Project For Major Pharmaceutical Company
May 18, 2022
-
BIMI Announces Appointment of New Chairman and Independent Director
May 18, 2022
-
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100
May 17, 2022
-
Bitech Technologies Provides Quarterly Shareholder Update with Growth Plan
May 16, 2022
-
BIMI Announces Appointment of Mr. Fnu Oudom to Board of Directors
May 12, 2022
-
New $90 million annual addressable market for QHSLab’s latest product, the Allergy Quick Test, branded AllergiQT(TM).
May 10, 2022
-
QHSLab. Issues Update and Investor Presentation May 2022
May 9, 2022
-
NUROSENE ANNOUNCES STRATEGIC AGREEMENT WITH BRAIN ANALYSIS PLATFORM, COVE NEUROSCIENCES INC.
May 6, 2022
-
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
May 4, 2022
-
Bitech Technologies Announces the Introduction of Tesdison, a Patented Self-Charging Technology to Provide a Green Energy Solution to Cryptocurrency Mining
May 2, 2022
-
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report
April 29, 2022